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Abstract
 .Fibroblasts derived from patients with late infantile neuronal ceroid lipofucsinosis NCL and from a mouse model of
 .NCL are similar to cells in intact animals in that they accumulate subunit 9 of mitochondrial F F -ATP synthase F-ATPase1 0
  . .Tanner, A., Dice, J.F., Cell Biol. Int. 19 1995 71–75 . We now report no differences in the synthetic rates of F-ATPase
subunit 9 in such affected cells when compared to control cells. However, the degradation rates of F-ATPase subunit 9 are
reduced in both the affected human and mouse cells. This reduced degradation applies only to subunit 9 and the
homologous vacuolar ATPase subunit among five distinct, reproducible proteolipid bands analyzed. Approximately 15% of
newly synthesized F-ATPase subunit 9 is rapidly degraded in control cells, but this rapidly degraded component is absent in
both the human and mouse NCL fibroblasts. At confluence, when the accumulated F-ATPase subunit 9 transiently
disappears from human NCL fibroblasts, there is an increased degradation of all proteolipids. The pathway of degradation
that is enhanced at confluence is likely to correspond to lysosomal macroautophagy. We confirmed that lysosomes were
able to degrade F-ATPase subunit 9 after endocytosis of radiolabeled mitochondria. Human NCL fibroblasts were less
active than control cells in this lysosomal degradation of endocytosed F-ATPase subunit 9. However, this difference was not
specific for F-ATPase subunit 9 since it also applied to total endocytosed mitochondrial protein. We conclude that
degradation of F-ATPase subunit 9 can occur by multiple pathways and that a mitochondrial pathway of proteolysis is
defective in the late infantile human and mouse forms of NCL. q 1997 Elsevier Science B.V.
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1. Introduction
 .Neuronal ceroid lipofuscinosis NCL , also re-
ferred to as Batten Disease, is a group of neurodegen-
erative lysosomal storage diseases characterized by
brain and retinal atrophy, blindness, seizures, paraly-
w xsis, and death 1,2 . Four different human forms of
the disease have been identified based on clinical
symptoms and age of onset; infantile, late infantile,
w xjuvenile, and adult NCL 3 . Several animal models
of NCL have been useful in the biochemical charac-
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terization of these diseases. Such models have been
described in several different animals including sheep,
w xdogs, cows, and mice 4–6 .
w xUnlike other known lysosomal storage diseases 7 ,
the material that accumulates within lysosomes in
NCL is largely protein. In the late infantile, juvenile,
and adult forms of NCL most of the accumulated
protein is the hydrophobic subunit 9 of the mitochon-
 . w xdrial F F -ATP synthase F-ATPase 8,9 . This pro-1 0
tein is also referred to as subunit c following the
.prokaryotic nomenclature for F-ATPase subunits .
This protein also accumulates in the sheep, dog, cow,
w xand mouse models of NCL 4–6 . A related protein, a
truncated form of the 17-kDa subunit of the vacuolar
 .ATPase V-ATPase , also accumulates to some ex-
w x tent in many of these forms of NCL 10 A. Brown
.and J. Faust, personal communication . In contrast,
the material that accumulates in infantile NCL con-
sists largely of the hydrophobic sphingolipid activator
w xproteins called saposins 11 .
The form of F-ATPase subunit 9 that accumulates
in NCL has been properly processed and, therefore,
has probably resided in mitochondria prior to its
w xstorage within lysosomes 14 . No obvious defects in
mitochrondrial function could be found in the sheep
w xmodel of NCL, so Palmer et al. 15 proposed that the
accumulation resulted from a defect in F-ATPase
subunit 9 degradation. Such a defect in degradation
was recently shown experimentally for fibroblasts
 .derived from late infantile NCL LINCL patients
w x16 . These studies also indicated that the reduced
degradation of subunit 9 was evident before this
protein could be found within lysosomes. This impor-
tant finding suggests that one pathway of degradation
of F-ATPase subunit 9 is intramitochondrial and that
this intramitochondrial pathway is defective in
LINCL. An additional lysosomal defect in the degra-
dation of F-ATPase subunit 9 in LINCL is also
possible.
Other published studies implicate lysosomal
macroautophagy in the degradation of mitochondrial
w xproteins 17,18 . However, quantitative studies in liver
indicate that macroautophagy can account for degra-
dation of no more than half of mitochondrial proteins
w x18 . Many other pathways of proteolysis exist within
w xcells including other lysosomal pathways 19,20 and
pathways that reside within organelles such as mito-
w x w xchondria 21 and the endoplasmic reticulum 22 . In
addition, the well-studied ubiquitinrproteasome
w xdegradation pathway 23 which resides largely in the
cytoplasm and nucleus can also be involved in mito-
chondrial degradation at least during reticulocyte
w xmaturation 24 . These considerations suggested to us
that F-ATPase subunit 9 may be degraded by multi-
ple pathways.
w xThe genes responsible for the infantile 12 and
w xjuvenile 13 forms of NCL have recently been identi-
fied. Mutations causing infantile NCL map to chro-
mosome 1 and lie within a gene encoding a palmitoyl
protein thioesterase, an enzyme required for the
degradation of lipid-modified proteins. Why such
mutations lead to saposin accumulation is unclear
since the saposins are not known to be lipid-mod-
ified. Mutations causing juvenile NCL reside on
chromosome 16 within a gene without sequence ho-
mology to other known proteins. The genes causing
late infantile and adult forms of NCL have not yet
been identified, but they appear to be different from
the infantile or juvenile NCL genes T. Lerner, per-
.sonal communication . How mutations in these dif-
ferent genes lead to the accumulation of F-ATPase
subunit 9 remains to be established. Certain muta-
tions may be in components of a proteolytic pathway
responsible for the degradation of subunit 9, and
other mutations may be in other components of the
same pathway. On the other hand, certain mutations
may slow the degradation of F-ATPase subunit 9
while others may cause the accumulation of this
protein for completely different reasons such as by
increasing its rate of synthesis.
Here we show that fibroblasts derived from a
LINCL patient and from the mndrmnd mouse model
of NCL have reduced degradation rates of F-ATPase
subunit 9 and the homologous V-ATPase proteolipid.
Reduced degradation is also evident for a rapidly
degraded fraction of subunit 9 presumably occurring
within mitochondria because the subunit 9 has been
processed to its mature form. In addition, we show
that the rates of degradation of F-ATPase subunit 9
and other proteolipids in human LINCL fibroblasts
depends on the growth status of the cells. For 4 days
following confluency the degradation of all prote-
olipids is increased. The pathway of proteolysis re-
sponsible for this increased degradation of prote-
olipids appears to correspond to lysosomal macroau-
tophagy.
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2. Materials and methods
2.1. Cells
Cells derived from a young, male LINCL patient
were kindly provided by Dr. Rose-Mary Boustany
 .Duke University School of Medicine, Durham, NC .
Control fibroblasts were also from a young male and
were designated CCD42SK by the American Tissue
 .Culture Collection Camden, NJ . Human lung fi-
 .broblasts IMR-90 were also from the American
Tissue Culture Collection. Skin fibroblasts from the
mndrmnd mice and the parental C57Blackr6 mice
were derived as follows: mice were killed by CO2
asphyxiation and were then dipped in 70% ethanol.
Their backs were shaved, and a 1=1-cm section of
skin was removed. The skin was minced with scissors
 .in Dulbecco’s Modified Eagle’s Medium DMEM
w xcontaining penicillin and streptomycin 25 and 5
mgrml collagenase Sigma Chemical Co., St. Louis,
.MO . After incubation for 15 min, the tissue was
disrupted by repeated pipeting and centrifuged at
180=g for 10 min. The pellet was resuspended in
DMEM, and aliquots were added to six-well culture
w xplates containing DMEM, antibiotics 25 , and 10%
 .  .vrv newborn calf serum NCS; Sigma . Other addi-
tives and conditions were as described previously
w x25 . Cells were passaged at confluence by trypsiniza-
tion and dilution 1:4. After approximately seven pop-
ulation doublings, the cells stopped growing but were
maintained by replacing the medium containing 10%
 .vrv NCS every 3 days. After 3–4 weeks scattered
foci of growing, spontaneously transformed cells were
visible, and these were allowed to form a confluent
monolayer before further passaging.
2.2. Protein synthesis
Confluent monolayers of cells were incubated with
w35 x  3583 mCirml of S methioninercysteine Tran S-
.label; ICN Biomedicals, Costa Mesa, CA in DMEM
w xcontaining antibiotics 25 , one-fifth of the usual me-
 .thionine and cysteine concentrations, and 10% vrv
NCS. At increasing times the medium was removed
and the monolayers were washed twice with 10 ml of
 .Hanks’ Balanced Salts Solution HBSS; Sigma con-
 .taining 5% vrv NCS followed by three times with
 . w x10 ml of phosphate-buffered saline PBS 26 . Sam-
ples were prepared and protein and radioactivity de-
termined as described below. Separate experiments
showed that all radioactivity associated with the
monolayer after these washings was in acid-precipita-
 .ble proteins J.F. Dice, unpublished results .
2.3. Protein degradation
2.3.1. Short-li˝ed proteins
Cells at confluence were labeled with 130 mCirml
w35 xof S methioninercysteine for 1 h as described
above for the protein synthesis measurements. The
radiolabeled medium was removed, and the monolay-
ers were then washed four times with 10 ml of HBSS
 . containing 5% vrv NCS. Medium DMEM con-
taining unlabeled methionine and cysteine, antibiotics
w x  . .25 , and 10% vrv NCS was replaced, and the
cells were incubated for increasing times. Separate
experiments showed that the unlabeled methionine
and cysteine in DMEM was sufficient to maximally
supress the reutilization of isotope J.F. Dice, unpub-
.lished results . Plates of cells were washed 4 times
with PBS, harvested, and processed for radioactivity
as described below.
2.3.2. Long-li˝ed proteins
Cells were labeled either beginning at 50% conflu-
ence for 3 days with 40 m Cirm l of
w35 xS methioninercysteine in DMEM containing nor-
mal amounts of methionine and cysteine, antibiotics
w x  .  .25 , and 10% vrv NCS Figs. 4–8 or beginning at
approximately 10% confluency for 3 days with 83
w35 xmCirml of S methioninercysteine in DMEM con-
taining normal amounts of methionine and cysteine,
w x  .  .antibiotics 25 , and 10% vrv NCS Figs. 2 and 3 .
The radiolabeled medium was removed and the
monolayers were then washed four times with 10 ml
 .of HBSS containing 5% vrv NCS. Medium
DMEM containing unlabeled methionine and cys-
w x  . .teine, antibiotics 25 , and 10% vrv NCS was
replaced, and the cells were incubated for increasing
times. To follow the degradation of long-lived pro-
teins for extended times in human cells Figs. 2 and
.3 , the cells were given fresh DMEM containing
w xunlabeled methionine and cysteine, antibiotics 25 ,
 .and 10% vrv NCS every 3 days. Plates of cells
were washed four times with PBS and harvested.
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2.4. Degradation of endocytosed mitochondria
Control human fibroblasts at 25% confluency were
incubated for 2 days with 100 mCirml of
w35 xS methioninercysteine in DMEM containing an-
w x  .tibiotics 25 and 10% vrv NCS. The cells were
harvested, homogenized, and subjected to density
gradient centrifugation according to the method of
w xStorrie and Madden 29 . The mitochondria were
collected, mixed with an equal volume of DMEM
 .containing 10% vrv NCS, and added to confluent
cultures of human LINCL or control cells. Endocyto-
sis was allowed to continue for 6 h, then the medium
was removed, and the monolayers were washed four
 .times with HBSS containing 5% vrv NCS. DMEM
containing unlabeled methionine and cysteine, antibi-
w x  .otics 25 , and 10% vrv NCS was replaced for 1 h
to chase the endocytosed mitochondria into lyso-
somes. A variety of endocytosed materials can be
chased into fibroblast lysosomes with incubations of
w x20–60 min 30 . Plates were again washed 4 times
 .with HBSS containing 5% vrv NCS, and then
DMEM containing unlabeled methionine and cys-
w x  .teine, antibiotics 25 , and 10% vrv NCS was
reapplied to the cultures. Cells were then harvested at
increasing times and radioactivity remaining in the
monolayer and in the ATPase subunit 9 band deter-
mined as described below.
2.5. Sample preparation and quantitation of radioac-
ti˝ity
 .Cells 12–24 culture plates, 100 mm diameter
were harvested by scraping into PBS and then pel-
leted by centrifugation at 180=g for 10 min. Cell
pellets were frozen at y808C and then thawed in 1
ml of 0.25 M sucrose containing 0.1% SDS and
sonicated at a microtip setting of 7 in a Branson
SonifierrCell Disrupter 185 VWR Scientific,
.Boston, MA for 10 s. Protein was determined by the
w xfluorescamine assay 27 . A small portion of the cell
homogenate was counted in a liquid scintillation
spectrophotometer, and an equivalent small portion
was saved for analysis of total proteins following
SDS–polyacrylamide gel electrophoresis SDS–
.PAGE . The remainder of the cell homogenate was
extracted with chloroform:methanol as described pre-
w xviously 10 and analyzed by SDS–PAGE on 16.5%
 .vrv polyacrylamide gels according to the method
w xof Schagger and vonJagow 28 . Gels were fixed,
dried, and applied to a phosphorimager screen. The
screens were analyzed using a Phosphorimager
 .Molecular Dynamics, Sunnyvale, CA . Quantitation
of radioactivity in various proteolipid bands was car-
ried after background subtraction using software and
procedures recommended by the manufacturer. The
location of the subunit 9 band at an apparent molecu-
w xlar weight of 3.1 kDa 10 was determined by using
radioactive low molecular weight standards Gibco–
.BRL, Grand Island, NY . Protein sequencing indi-
cated that )95% of the protein in this band was
 .F-ATPase subunit 9 J.F. Dice, unpublished results .
2.6. Antibodies
Antibodies to F-ATPase subunit 9 were raised
against the amino terminal peptide sequence as de-
w xscribed 31 . Antibodies to the 17-kDa V-ATPase
subunit were raised against the internal peptide,
DAGKRGTAQQPR. The peptide was synthesized
with a cysteine at the amino terminus for subsequent
coupling to keyhole limpet hemocyanin. These anti-
bodies were a gift of Dr. Jerry Faust of this depart-
ment. The antibodies to the V-ATPase subunit were
used to identify this protein after separation of prote-
olipids by SDS–PAGE and transfer to nitrocellulose.
w35 xFig. 1. Rates of uptake of S MetrCys into F-ATPase subunit 9
by NCL and control fibroblasts. Cells were radiolabeled as
described in Section 2. Radioactivity incorporated into F-ATPase
subunit 9 was quantitated following SDS–PAGE of proteolipids.
Data shown are averages "1 S.D. of three to six separate
determinations. LINCL refers to fibroblasts from the late infantile
neuronal ceroid lipofuscinosis human patient, and MND refers to
fibroblasts derived from the mndrmnd mouse.
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Fig. 2. Reduced degradation of F-ATPase subunit 9 in human
LINCL fibroblasts. Cells were radiolabeled and chased as de-
 .scribed in Section 2. Degradation of total protein A , prote-
 .  .olipids B , and F-ATPase subunit 9 C are shown. The total
protein and proteolipid data are derived from direct counting of
radioactivity in these protein fractions while the data for F-ATPase
subunit 9 are from Phosphorimager analysis following SDS–
PAGE. Data shown are averages "1 S.D. of three to six separate
determinations. The numbers on the figure refer to the half-life
 .h of the indicated portions of the decay curves as calculated by
 .Fig. P software BioSoft, Cambridge, UK .
3. Results
We measured rates of synthesis of F-ATPase sub-
unit 9 in both the human and mouse NCL fibroblasts
as well as their corresponding control cells. Fig. 1
shows the results of three to six separate experiments.
Synthetic rates were identical for the NCL and con-
trol cells suggesting that the accumulation of F-
ATPase subunit 9 in NCL cells must be due to
reduced degradation. We obtained similar results
when the time course of protein synthetic measure-
 .ments was extended to 24 h data not shown .
We followed the degradation of long-lived proteins
in human fibroblasts over a long time course in
culture because we anticipated that degradation rates
of F-ATPase subunit 9 might vary with the culture
w xconditions 31 . Degradation rates for total protein
 .  .Fig. 2A and proteolipids Fig. 2B were similar for
LINCL and control fibroblasts. However, degradation
of F-ATPase subunit 9 was reduced in LINCL fibrob-
 .lasts when compared to control cells Fig. 2C .
Fig. 3. Reduced degradation of V-ATPase subunit 9, but not
three other proteolipids, in human LINCL fibroblasts. Analysis of
other distinct proteolipid bands was carried out for the same
experiments used to analyze the degradation rates of F-ATPase
 .subunit 9 Fig. 2C . Data shown are average "1 S.D. of three to
six separate determinations.
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F-ATPase subunit 9 accounted for approximately
15% of the total proteolipid radioactivity. Four other
reproducible proteolipid bands were evident, and the
five bands together accounted for 60% of the prote-
Fig. 4. Reduced degradation of F-ATPase subunit 9 in mouse
NCL fibroblasts. Cells were radiolabeled and chased as described
 .  .in Section 2 for total protein A , proteolipids B , or F-ATPase
 .subunit 9 C . The results shown are a representative example of
three separate experiments. The best-fit lines were calculated by
 .linear regression using Fig. P software Biosoft, Cambridge, UK .
 .The numbers on the figures refer to half-lives h . MND refers to
fibroblasts derived from the mndrmnd mouse.
Fig. 5. Reduced degradation of V-ATPase subunit 9, but not
other proteolipids, in mouse NCL fibroblasts. Analysis of other
distinct proteolipid bands was carried out for the same experi-
ments used to analyze the degradation rates of F-ATPase subunit
 .9 Fig. 4C, for example . Data shown are averages "1 S.D. of
three separate determinations. MND refers to fibroblasts derived
from the mndrmnd mouse.
olipid radioactivity. We also analyzed the degradation
rates of the four other proteolipid bands in the human
cells. Fig. 3 shows that the other proteolipids were
degraded more rapidly than F-ATPase subunit 9 and
that the only other proteolipid that was degraded
more slowly in the LINCL fibroblasts was a band
with an apparent molecular mass of 12.0 kDa Fig.
.3D . We identified this band as the 17-kDa subunit of
the V-ATPase by immunoblotting with antibodies
 .specific for this protein see Section 2 . However, we
cannot rule out the possibility that some proteolipid
in this band is also aggregated F-ATPase subunit 9
 .14 .
We also measured protein degradation beginning
at confluency with the mouse fibroblasts. The mouse
cells accumulate F-ATPase subunit 9 under all cul-
w xture conditions 31 , so the time course of measure-
ments was of less importance than with the human
cells. Fig. 4 shows a representative result from three
separate experiments. The mouse cells showed simi-
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 .lar rates of degradation for total proteins Fig. 4A .
Proteolipids were degraded slightly more slowly in
 .mndrmnd cells in this experiment Fig. 4B , but not
in the other two replicate experiments. Degradation
 .rates for F-ATPase subunit 9 were reduced Fig. 4C ,
and this result applied to every time point of all three
experiments. We obtained a similar result with skin
fibroblasts derived from another mndrmnd and con-
 .trol mouse data not shown . These studies demon-
strate that the cause of the accumulation of subunit 9
in the mndrmnd mouse is also a reduction in the
degradation rate of this protein.
Analysis of the degradation of four other prote-
olipids in the mouse cells showed that they were
degraded more rapidly than the F-ATPase subunit 9
and that only the related V-ATPase 17-kDa subunit,
Fig. 6. The absence of a rapidly degraded pool of F-ATPase subunit 9 in human and mouse NCL fibroblasts. Cells were radiolabeled and
 .  .chased as described in Section 2. A–C Human LINCL fibroblasts; D–F mouse fibroblasts. Data shown are a representative result from
three separate experiments. MND refers to fibroblasts derived from the mndrmnd mouse.
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Fig. 7. Increased degradation of proteolipids in human NCL
fibroblasts after reaching confluence. Cells were radiolabeled and
 .chased as described in Section 2 for total protein A , proteolipids
 .  .B , or F-ATPase subunit 9 C . The results shown are a repre-
sentative example of three separate experiments. The best-fit
lines were calculated by linear regression using Fig. P software
 .Biosoft, Cambridge, UK . The numbers on the figures refer to
 .half-lives h .
identified as described in Section 2, was degraded
 .more slowly in mouse NCL fibroblasts Fig. 5 simi-
lar to our findings with the human LINCL fibroblasts.
Many subunits of multimeric proteins are synthe-
sized in excess, and the extra molecules are rapidly
w xdegraded 22 . To determine whether a fraction of
newly synthesized F-ATPase subunit 9 was rapidly
degraded, we pulse-labeled cells for 1 h and then
followed degradation over a short time course. Fig. 6
shows results representative of three separate experi-
ments. Fig. 6A shows that short-lived proteins were
evident among the total proteins analyzed as has also
w xbeen shown for many other cells in culture 32–34 .
For unknown reasons human LINCL cells had slightly
more rapid degradation rates of these short-lived
 .proteins than did the control cells Fig. 6A . There
were also short-lived proteins among the proteolipids
Fig. 8. Proteolipid degradation in human fibroblasts under vary-
ing culture conditions. Cells were radiolabeled as described for
long-lived proteins in Section 2. Cells were then trypsinized and
replated at 2=106 cells per dish to study degradation in conflu-
ent cultures or 2=105 cells per dish to study degradation in log
growth cultures. For these comparisons, cells were allowed to
adhere to the culture dish for 3 h before the degradation measure-
ments were begun. SP, sparsely growing cells; CON, confluent
cells. Certain confluent cultures contained 20 mM NH Cl in the4
 .degradation medium as indicated A and others were incubated
 .  .  .  .with qS or without yS 10% vrv NCS in the medium B
as indicated. Degradation curves were constructed see Fig. 2, for
.example and half-lives were converted to degradation rates by
the formula, Rs ln2rT1r2. Results shown are averages "1
S.D. for four to eight separate determinations.
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 .analyzed Fig. 6B . Once again, these short-lived
proteins were more rapidly degraded in LINCL cells
than in control cells. Fig. 6C shows that a portion of
newly synthesized F-ATPase subunit 9 was short-
lived in control cells. However, a short-lived popula-
tion of subunit 9 was not evident in the LINCL
fibroblasts. This result was obtained in each of the
three separate experiments. Fig. 6D–F show equiva-
lent results for the mouse NCL fibroblasts. In this
case the control and mndrmnd fibroblasts had equal
rates of degradation of short-lived total protein Fig.
.6D , but the mndrmnd cells had reduced degradation
 .rates of short-lived proteolipids Fig. 6E as well as
 .short-lived subunit 9 Fig. 6F . These results were
obtained in each of the three separate experiments.
When the human LINCL fibroblasts reach conflu-
ence, they transiently lose the accumulated subunit 9
w x31 . To study protein degradation during this time,
proteolysis was followed beginning when the cells
reached confluence. There was no difference in the
degradation rates of total protein between the LINCL
 .and the control cells Fig. 7A , and the half-life
values were in agreement with the previous longer
 .term degradation study Fig. 2 . However, at conflu-
ence the LINCL fibroblasts had increased rates of
 .degradation of proteolipids. Fig. 7B . This increase
in degradation rate was not significant for subunit 9
 .Fig. 7C but was more striking for other proteolipids
 .data not shown .
When cultured cells reach confluence lysosomal
w xpathways of proteolysis are known to increase 35,36 .
In nontransformed cells the lysosomal pathway stim-
ulated at confluence is known to be macroautophagy
w x33,35,36 . In transformed cells macroautophagy is
w xstimulated at confluence to a lesser extent 35 . If
macroautophagy were responsible for the rapid
degradation of proteolipids as cells reach confluence,
degradation rates of proteolipids should be dramati-
cally slower in logarithmically growing, subconfluent
cells. We compared degradation rates for total pro-
teins and for proteolipids in logarithmically growing
and confluent human NCL fibroblasts. Fig. 8A shows
that total proteins were more stable in logarithmically
growing cells and that proteolipids were stabilized to
an even greater extent. We obtained similar results
for the control cells except that the difference in
degradation rates of proteolipids between logarithmi-
cally growing and confluent cells was not as great
 .data not shown . If a lysosomal pathway is responsi-
ble for the increased degradation of proteolipids at
confluence, their degradation should be partially in-
hibited by lysosomotrophic agents such as NH Cl.4
Fig. 8A shows such an inhibition for the increased
degradation of total proteins and of proteolipids as
cells reach confluence.
A selective pathway of lysosomal proteolysis also
exists and is activated by the withdrawal of serum
w xgrowth factors 19 . Skin fibroblasts do not exhibit
 .this pathway of proteolysis data not shown , but lung
fibroblasts do. We used human lung fibroblasts
 .IMR-90; see Section 2 to determine whether or not
this selective pathway of lysosomal proteolysis could
also be responsible for the degradation of prote-
olipids. The results shown in Fig. 8B show that total
proteins were degraded more rapidly in the absence
Fig. 9. Degradation of F-ATPase subunit 9 and total mitochon-
drial proteins after endocytosis of mitochondria. Mitochondria
from control human fibroblasts were radiolabeled as described in
Section 2. Degradation of F-ATPase subunit 9 was followed by
 .Phosphorimager analysis following SDS–PAGE A , and degra-
dation of total mitochondrial proteins was followed by determin-
 .ing the radioactivity remaining in cells at increasing times B .
Results shown are average "1 S.D. for three separate experi-
 .  .ments in control open and LINCL closed human fibroblasts.
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of serum, but this condition did not affect the degra-
dation rate of proteolipids.
We also analyzed whether lysosomes from LINCL
human fibroblasts were defective in the degradation
of F-ATPase subunit 9 following endocytosis of radi-
olabeled mitochondria derived from control human
 .fibroblasts CCD42SK . Fig. 9A shows that both
control and LINCL fibroblasts were able to degrade
endocytosed F-ATPase subunit 9, but LINCL fibrob-
lasts had a reduced ability to degrade F-ATPase
subunit 9 when compared to control cells. This re-
duced degradation was not specific for F-ATPase
subunit 9, however Fig. 9B shows that the LINCL
fibroblasts also had a reduced ability to degrade total
mitochondrial proteins following endocytosis. When
corrected for the different abilities to degrade total
mitochondrial proteins, no specific difference in the
degradation of F-ATPase subunit 9 was evident be-
 .tween control and affected cells data not shown .
4. Discussion
Our results confirm and extend those reported by
w xEzaki et al. 16 showing a defect in the degradation
of F-ATPase subunit 9 in fibroblasts derived from
LINCL patients. We also find this defective degrada-
tion in fibroblasts from another LINCL patient Fig.
.2 as well as in fibroblasts from the mndrmnd mouse
 .model of NCL Fig. 4 . The defective proteolysis of
F-ATPase subunit 9 most likely represents a mito-
chondrial pathway of degradation for the following
 .reasons: a a degradation defect also applies to a
rapidly turning over portion of the mature F-ATPase
subunit 9 presumably occuring in mitochondria Fig.
.  .6 , b lysosomal degradation of F-ATPase subunit 9
by macroautophagy appears to be able to degrade
F-ATPase subunit 9 and other proteolipids in LINCL
 .  .and control cells Figs. 7 and 8 , and c the reduced
ability of lysosomes to degrade endocytosed F-
ATPase subunit 9 applies also to total mitochondrial
 .proteins Fig. 9 and is, therefore, likely to be a
secondary consequence of the F-ATPase subunit 9
and other material stored in lysosomes.
Our measured half-life for total cell proteins 60–
.70 h is in agreement with that reported by Ezaki et
w xal. 16 . However, they reported the half-life of F-
ATPase subunit 9 to also be in the range of 60–70 h
while we reproducibly find it to have a longer half-life
in both human and mouse NCL fibroblasts 95–145
.h . The reasons for this discrepancy are unclear.
w xEzaki et al. 16 followed degradation of F-ATPase
subunit 9 following immunoprecipitation, and it seems
possible that the antibodies failed to recognize a
slowly degraded population of this protein. On the
other hand, our gel analysis may contain another
proteolipid within the F-ATPase subunit 9 band.
Based on sequence analysis of this band, another
comigrating protein could represent no more than 5%
 .of the total J.F. Dice, unpublished results . This
putative protein would have to be very long-lived to
account for our longer measured half-lives.
We have also analyzed other unidentified but re-
producible proteolipid bands from the same degrada-
tion experiments. The defect in degradation does not
apply to all proteolipids but is specific for F-ATPase
subunit 9 and the related proteolipid, the 17-kDa
 .subunit of the V-ATPase, in both the human Fig. 3
 .and the mouse Fig. 5 cells. Although we identified
this protein band immunologically as the 17-kDa
subunit of the V-ATPase in both human and mouse
cells, we cannot exclude the possibility that this band
also contained some aggregated F-ATPase subunit 9
w xas is sometimes seen after SDS–PAGE 14 .
The five distinct proteolipid bands in the human
and mouse fibroblasts were not all of corresponding
molecular masses. The slowest migrating proteolipid
band in both the human and mouse cells reacted with
the antibody to the 17-kDa subunit of the V-ATPase,
confirming that this proteolipid has a different molec-
ular mass in human and mouse cells. The 17-kDa
subunit of V-ATPase that accumulates in the
mndrmnd mouse is known to be a truncated form
w xmost likely due to limited proteolysis 10 . The higher
molecular mass of this proteolipid in the human
LINCL fibroblasts suggests that it may be the full
sized proteolipid. The reasons for other differences in
proteolipid sizes in human and mouse fibroblasts are
not known.
We conclude that the defect in proteolipid degrada-
tion in human LINCL and in the mndrmnd mouse
cells is selective but that it likely applies to two
proteins residing in different intracellular organelles.
The defect in degradation of F-ATPase subunit 9 may
be primary and only when this hydrophobic protein
accumulates in lysosomes is the degradation of the
( )A. Tanner et al.rBiochimica et Biophysica Acta 1361 1997 251–262 261
V-ATPase subunit reduced. Alternatively, the defect
in degradation of the V-ATPase proteolipid may be
the primary defect in NCL. It is also possible that the
reduced degradation of both proteins represent sec-
ondary consequences of some other basic metabolic
w xdeficiency in NCL 1,2 . Further experimentation is
required to resolve these questions.
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